Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Publication | Closed Access

DOI

761

Citations

References

2018

Year

Pascal Vranckx, Marco Valgimigli, Peter Jüni, Christian W. Hamm, Philippe Gabríel Steg, Dik Heg, Gerrit Anne van Es, Eugène McFadden, Yoshinobu Onuma, Cokky van Meijeren,

The Lancet

Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapySurgeryTicagrelor MonotherapyMedicinePlatelet AntagonistAtherosclerosisDrug-eluting Stent